These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 17015275

  • 1. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels.
    Selmeci L, Székely M, Soós P, Seres L, Klinga N, Geiger A, Acsády G.
    Free Radic Res; 2006 Sep; 40(9):952-8. PubMed ID: 17015275
    [Abstract] [Full Text] [Related]

  • 2. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.
    Valli A, Suliman ME, Meert N, Vanholder R, Lindholm B, Stenvinkel P, Watanabe M, Barany P, Alvestrand A, Anderstam B.
    Clin Chim Acta; 2007 Apr; 379(1-2):87-94. PubMed ID: 17292872
    [Abstract] [Full Text] [Related]

  • 3. Effect of blood sample type on the measurement of advanced oxidation protein products as a biomarker of inflammation and oxidative stress in hemodialysis patients.
    Chen YH, Shi W, Liang XL, Liang YZ, Fu X.
    Biomarkers; 2011 Mar; 16(2):129-35. PubMed ID: 21133645
    [Abstract] [Full Text] [Related]

  • 4. The plasma concentration of advanced oxidation protein products and arterial stiffness in apparently healthy adults.
    Wykretowicz A, Adamska K, Krauze T, Guzik P, Szczepanik A, Rutkowska A, Wysoki H.
    Free Radic Res; 2007 Jun; 41(6):645-9. PubMed ID: 17516236
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C, Köse K, Caliş M, DemIr M, Kirnap M, Ateş F.
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [Abstract] [Full Text] [Related]

  • 8. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.
    Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T, Descamps-Latscha B.
    J Immunol; 1998 Sep 01; 161(5):2524-32. PubMed ID: 9725252
    [Abstract] [Full Text] [Related]

  • 9. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome.
    Skvarilová M, Bulava A, Stejskal D, Adamovská S, Bartek J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun 01; 149(1):83-7. PubMed ID: 16170393
    [Abstract] [Full Text] [Related]

  • 10. Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis?
    Rysavá R, Kalousová M, Zima T, Dostál C, Merta M, Tesar V.
    Kidney Blood Press Res; 2007 Jun 01; 30(1):1-7. PubMed ID: 17191033
    [Abstract] [Full Text] [Related]

  • 11. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A, Knapik-Kordecka M, Szczecińska J, Warwas M.
    Diabetes Metab Res Rev; 2008 Oct 01; 24(7):549-53. PubMed ID: 18613218
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Levels of advanced oxidation protein products (AOPP) in the first trimester of pregnancy].
    Fialová L, Kalousová M, Soukupová J, Malbohan I, Krofta L, Mikulíková L, Horejsová H, Stípek S, Zima T.
    Sb Lek; 2003 Oct 01; 104(1):95-102. PubMed ID: 14577140
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Oxidative stress and endothelium dysfunction in diabetes mellitus type 2].
    Piwowar A, Knapik-Kordecka M, Warwas M.
    Pol Merkur Lekarski; 2008 Aug 01; 25(146):120-3. PubMed ID: 18942329
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.